Cookie News
English Português English English French Français German Deutsch Dutch Nederlands Japanese 日本語 Spanish Español

Blue Origin Beats SpaceX in NASA Mars Mission Bid

Science 3 days ago

Blue Origin has emerged victorious in NASA’s competitive bidding process for the upcoming Mars mission, edging out rival SpaceX. The contract represents a significant milestone for Jeff Bezos’ aerospace company, which has been developing its New Glenn rocket system for deep space missions. NASA officials cited Blue Origin’s innovative landing technology and payload capacity as key factors in their decision.

The selection comes as a surprise to many industry observers who expected SpaceX’s established track record with NASA to prevail. However, Blue Origin’s recent successful test flights and reusable rocket advancements appear to have tipped the scales. The Mars mission will utilize Blue Origin’s heavy-lift capabilities to deliver critical scientific instruments to the Red Planet.

This development intensifies the billionaire space race between Bezos and Musk, with both companies vying for dominance in the new era of commercial space exploration. The Mars mission launch is scheduled for 2026, giving Blue Origin time to finalize its spacecraft design and conduct additional testing. NASA administrators emphasize this partnership will accelerate humanity’s goal of establishing a sustained presence on Mars.

Blue Origin Beats SpaceX in NASA Mars Mission Bid



NASA Plans Lunar Nuclear Reactor by 2030
Exploring the Universe: Discoveries Beyond Our Solar System
Science Storytellers: The TOI Science Desk’s Quest for Discovery
Exploring the Wonders of Science with TOI Science Desk
Microwaving Mining Waste to Capture CO2: A Breakthrough in Carbon Removal
The Mystery of the Nameless Ancient Humans
Ancient 2 Billion-Year-Old Water Discovered by Scientist
Ancient ’Deceptively Cute’ Whale Unearthed in Australia
Zombie Rabbits: The Real Story Behind Colorado’s Viral ’Demon Bunnies’
AI Translates Imagined Speech into Spoken Words for Paralysis Patients